Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    The press release archive now adds Research and Research and Pipeline categories and includes new items such as HYMPAVZI approval and Berobenatide dosing with dates, while removing older items from Finance/Corporate sections (e.g., shareholder meeting preliminary results and VYNDAMAX settlements).
    Difference
    3%
    Check dated 2026-06-13T00:18:57.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    New June 2026 and May 2026 press release entries have been added to the archive, including Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference and other May releases. A set of April 2026 items has been removed from the archive.
    Difference
    9%
    Check dated 2026-06-05T22:47:25.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Three new May 2026 press releases were added to the archive (05.29.2026 Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer; 05.28.2026 Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines; 05.27.2026 Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference). Additionally, several older March 2026 entries were removed from the archive as part of ongoing content updates.
    Difference
    9%
    Check dated 2026-05-29T22:51:00.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The archive adds Research and Research and Pipeline sections and a new May 20, 2026 press release title about a pediatric pneumococcal vaccine program; it also removes Finance and Financial categories and an older press item about a mini-tender offer.
    Difference
    1%
    Check dated 2026-05-22T16:55:29.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added: European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors (05.13.2026). Deleted: TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer (03.19.2026).
    Difference
    1%
    Check dated 2026-05-15T14:40:18.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    A new May 5, 2026 press release entry was added to the archive under May 2026; the archive also removes the Research and Research and Pipeline categories and deletes the 03.17.2026 press release about Atirmociclib.
    Difference
    1%
    Check dated 2026-05-08T12:18:06.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.